<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(5)</volume><submitter>Jang EJ</submitter><pubmed_abstract>&lt;h4>Objectives&lt;/h4>We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) as of April 2022 using the national registry.&lt;h4>Methods&lt;/h4>We used the national coronavirus disease 2019 (COVID-19) infection and vaccination registry from South Korea, as described to define individuals with a previous history of COVID-19 infection, vaccination, or both, as persons with presumed immunity.&lt;h4>Results&lt;/h4>Of a total of 53,304,627 observed persons, 24.4% had vaccination and infection, 58.1% had vaccination and no infection, 7.6% had infection and no vaccination, and 9.9% had no immunity. The SARS-CoV-2 Omicron variant emerged at a time when the presumed population immunity ranged from 80</pubmed_abstract><journal>Osong public health and research perspectives</journal><pagination>377-381</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9633270</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Presumed population immunity to SARS-CoV-2 in South Korea, April 2022.</pubmed_title><pmcid>PMC9633270</pmcid><pubmed_authors>Lee S</pubmed_authors><pubmed_authors>Choe YJ</pubmed_authors><pubmed_authors>Kim YY</pubmed_authors><pubmed_authors>Jang EJ</pubmed_authors><pubmed_authors>Lim DS</pubmed_authors><pubmed_authors>Choe SA</pubmed_authors><pubmed_authors>Park YJ</pubmed_authors><pubmed_authors>Yi S</pubmed_authors><pubmed_authors>Kim J</pubmed_authors><pubmed_authors>Kim RK</pubmed_authors><pubmed_authors>Lee JH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Presumed population immunity to SARS-CoV-2 in South Korea, April 2022.</name><description>&lt;h4>Objectives&lt;/h4>We estimated the overall and age-specific percentages of the Korean population with presumed immunity against severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) as of April 2022 using the national registry.&lt;h4>Methods&lt;/h4>We used the national coronavirus disease 2019 (COVID-19) infection and vaccination registry from South Korea, as described to define individuals with a previous history of COVID-19 infection, vaccination, or both, as persons with presumed immunity.&lt;h4>Results&lt;/h4>Of a total of 53,304,627 observed persons, 24.4% had vaccination and infection, 58.1% had vaccination and no infection, 7.6% had infection and no vaccination, and 9.9% had no immunity. The SARS-CoV-2 Omicron variant emerged at a time when the presumed population immunity ranged from 80</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-25T23:23:22.644Z</modification><creation>2025-04-06T09:23:24.196Z</creation></dates><accession>S-EPMC9633270</accession><cross_references><pubmed>36328242</pubmed><doi>10.24171/j.phrp.2022.0209</doi></cross_references></HashMap>